# 바이오스페이스 일일 뉴스 리포트 - 2025년 04월 29일


## 주요 헤드라인

1. **Pfizer’s Subcutaneous PD-1 Cuts Risks in Bladder Cancer but Misses Survival Endpoint (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/pfizers-subcutaneous-pd-1-cuts-risks-in-bladder-cancer-but-misses-os-endpoint>

2. **Pfizer’s Subcutaneous PD-1 Cuts Risks in Bladder Cancer but Misses Survival Endpoint (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/pfizers-subcutaneous-pd-1-cuts-risks-in-bladder-cancer-but-misses-os-endpoint>

3. **J&J Declares ‘Sustained Disease Control’ With Bladder Cancer Drug-Device Combo (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/j-j-declares-sustained-disease-control-with-bladder-cancer-drug-device-combo>

4. **AACR 2025 Tracker (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/aacr-2025-tracker-gsk-boehringer-ingelheim-kick-off-meeting-with-new-data>

5. **Perioperative Keytruda Cuts Risk of Negative Events by Over 25% in Head and Neck Cancer (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/perioperative-keytruda-cuts-risk-of-negative-events-by-over-25-in-head-and-neck-cancer>

6. **Merck KGaA Moves Ahead on SpringWorks Buy for $3.9B (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/springworks-surges-on-potential-3-5b-merck-kgaa-buyout>

7. **Merck, Boehringer Ingelheim, More To Present Key Data at AACR ’25 (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/merck-boehringer-ingelheim-more-to-present-key-data-at-aacr-25>


---
*2025년 04월 29일 바이오스페이스 뉴스 피드에서 생성된 리포트*